PLIANT THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $199.1M | $51.7M |
| FY2022 | $9.9M | $313.3M | $33.7M |
| FY2023 | $10.1M | $473.6M | $63.2M |
| FY2024 | $30.2M | $304.1M | $71.2M |
| FY2025 | $0 | $181.2M | $45.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $199.1M | $51.7M |
| FY2022 | $9.9M | $313.3M | $33.7M |
| FY2023 | $10.1M | $473.6M | $63.2M |
| FY2024 | $30.2M | $304.1M | $71.2M |
| FY2025 | $0 | $181.2M | $45.4M |